Boston Scientific determined to gain ground in medical device sales in emerging markets

Featured Story

Boston Scientific determined to gain ground in medical device sales in emerging markets

March 2, 2014 10:03 am by | 0 Comments

If emerging-market revenue were a horse race, Boston Scientific would be bringing up the rear. But the medical device maker is fervently determined to gain ground, with stepped-up efforts to…


Boston Scientific’s anti-stroke medical device gets mixed results in trial

Boston Scientific’s anti-stroke medical device gets mixed results in trial

December 9, 2013 10:27 am by | 0 Comments

Dec 9 (Reuters) – Boston Scientific Corp’s anti-stroke device did not meet one measure of success in a clinical study of the implant, but other data must be considered when…


BSX scores FDA device approval for drug-eluting stent for coronary artery disease patients

BSX scores FDA device approval for drug-eluting stent for coronary artery disease patients

November 25, 2013 9:55 am by | 0 Comments

Boston Scientific (BSX) received FDA device approval for its Promus PREMIER Everolimus-Eluting Platinum Chromium Coronary Stent System, a next-gen polymer drug-eluting stent. The product launches immediately in the U.S. It will…



Boston Scientific appoints new investor relations VP

Boston Scientific appoints new investor relations VP

November 22, 2013 9:29 am by | 0 Comments

Boston Scientific (BSX) has taken its new investor relations VP from Abiomed (ABMD), the company known for the world’s smallest heart pump and AbioCor. Susan Lisa has served as the…


Boston Scientific gets FDA clearance and CE Mark for embolization catheter

Boston Scientific gets FDA clearance and CE Mark for embolization catheter

November 20, 2013 10:52 am by | 0 Comments

Boston Scientific (BSX) received FDA clearance and the CE Mark for its Direxion Torqueable Microcatheter. The catheter is the company’s newest addition to its peripheral embolization medical device technology portfolio. Radiologists…


BSX receives CE Mark for deep brain stimulation system as dystonia treatment

BSX receives CE Mark for deep brain stimulation system as dystonia treatment

November 19, 2013 8:51 am by | 0 Comments

Boston Scientific (BSX) announced it has received the CE Mark for its Vercise Deep Brain Stimulation System for the treatment of dystonia, “a neurological movement disorder characterized by involuntary muscle…


Bet on Medtronic winning the MDT vs. BSX Supreme Court case. Here’s why

Bet on Medtronic winning the MDT vs. BSX Supreme Court case. Here’s why

November 6, 2013 9:13 am by | 0 Comments

The Supreme Court heard oral arguments in Medtronic (MDT) vs. Boston Scientific (BSX) in a patent litigation lawsuit Tuesday. Chances are the Minnesota-based medical device company will win this one….


Boston Scientific closes Bard EP acquisition

Boston Scientific closes Bard EP acquisition

November 4, 2013 9:20 am by | 0 Comments

Healthcare business intelligence: Boston Scientific (BSX) closed on its acquisition of C.R. Bard‘s Bard EP Nov. 1. According to a company statement, the addition of Bard’s advanced therapeutic catheters, diagnostic catheters, electrophysiology…



Two top medical device companies announce promising renal denervation tech results

Two top medical device companies announce promising renal denervation tech results

October 29, 2013 9:59 am by | 1 Comments

Two top medical device companies turned up the heat on the renal denervation competition. Both Boston Scientific (BSX) and St. Jude Medical (STJ) delivered promising results from studies on their…


BSX scores CE Mark for Lotus Valve System for patients with severe aortic stenosis

BSX scores CE Mark for Lotus Valve System for patients with severe aortic stenosis

October 28, 2013 1:17 pm by | 0 Comments

Boston Scientific (BSX) announced the medical device company has received a CE Mark for its Lotus Valve System, which offers alternative treatment for high-risk patients with sever aortic stenosis. The…


Boston Scientific names new CFO for 2014, introduces company restructuring plan

Boston Scientific names new CFO for 2014, introduces company restructuring plan

October 24, 2013 9:54 am by | 0 Comments

A changing of the guard: Dan Brennan will become Boston Scientific‘s (BSX) new CFO effective Jan. 1. Company CFO  Jeffrey Capello will stay with the company through May to help…


BSX to pay $30M to end allegations Guidant sold defective defibrillators to Medicare

BSX to pay $30M to end allegations Guidant sold defective defibrillators to Medicare

October 17, 2013 2:20 pm by | 0 Comments

Guidant continues to prove itself as Boston Scientific’s biggest legal headache. Reuters reports Boston Scientific (BSX) has agreed to pay a $30 million settlement to bring two-year civil lawsuit, and with…


FDA grants Neuros Medical IDE approval to conduct clinical trial for pain management technology for amputees

FDA grants Neuros Medical IDE approval to conduct clinical trial for pain management technology for amputees

October 10, 2013 2:38 pm by | 0 Comments

Neuros Medical, a Cleveland-based medical device company, received an FDA investigational device exemption approval to begin a clinical study on its technology for intractable limb pain management for amputees. According…


Could this device lead to shorter labor and delivery + become childbirth standard of care?

Could this device lead to shorter labor and delivery + become childbirth standard of care?

September 18, 2013 11:59 am by | 27 Comments

Materna Medical is at work on a device to help protect the more than 80 percent of women who suffer damage or tearing during childbirth. “The clinical need we’re trying…


BSX pays out to OrbusNeich to settle stent lawsuit woes

BSX pays out to OrbusNeich to settle stent lawsuit woes

September 17, 2013 10:00 am by | 0 Comments

Boston Scientific (BSX) has agreed to make an undisclosed, one-time payment to OrbusNeich to settle all stent-based litigation. This includes settling lawsuits in the United States, the Netherlands, Ireland, Germany…


Will this 2013 Innovation of the Year device change the standard of care for port site closures?

Will this 2013 Innovation of the Year device change the standard of care for port site closures?

August 28, 2013 12:52 pm by | 0 Comments

The standard of care for port site closures in laparoscopic surgery may be changing. Irish medical device startup neoSurgical‘s first commercialized product, neoClose, officially launched this week in the U.S. Today,…